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The nuclear receptor superfamily is comprised of over 150 
different proteins that have evolved to mediate a complex 
array of extracellular signals into transcriptional re- 
sponses. Many, but not all, of these proteins directly bind 
to signaling molecules, which, because of their small lipo- 
philic character, can easily enter the target cell. Thus, un- 
like membrane-bound receptors, the nuclear receptors are 
intracellular and function to control the activity of target 
genes directly. In aggregate, these target genes comprise 
a genetic network whose coordinate activity defines the 
physiologic response. The purpose of this review is to es- 
tablish the historical links between the steroid and nonste- 
roid receptor signaling systems, to chart the explosive de- 
velopment of the retinoid X receptor (RXR) heterodimer 
and orphan receptor family, to explain the impact of these 
discoveries on our understanding of the mechanisms of 
hormonal signaling, and, finally, to present emerging is- 
sues and implications of these studies for animal develop- 
ment, physiology, and human disease. 
Mechanism of Action 
Although the principle mechanism of action of heterodi- 
merit and orphan receptors is similar to that for the steroid 
hormone receptors, there are several important differ- 
ences. In contrast with the steroid receptors, the ligands 
for this family are chemically diverse, including vitamin D, 
thyroid hormone, retinoids, and prostanoids. Furthermore, 
not all of these ligands are exclusively endocrine, and they 
may be activated by metabolic pathways within the target 
cells (Figure 1). Others may be entirely produced in the 
target cell and thus have no true hormonal feature. In addi- 
tion, as will be discussed below, not all members of this 
family can be expected to be hormone responsive, sug- 
gesting that alternative ligand-independent pathways for 
activation exist. Phosphorylation is one potential candi- 
date for mediating receptor function by such a pathway 
(reviewed by Weigel, 1994). Another mechanism bywhich 
receptors can modulate gene expression is by cross- 
coupling to augment or inhibit signaling pathways medi- 
ated by other classes of transcription factors. Perhaps the 
best example is the inhibition of AP-1 (JunlFos) action by 
glucocorticoids, retinoids, and thyroid hormones (Pfahl, 
1993; reviewed by Beato et al., 1995 [this issue of Cc//l). 
While the molecular basis of these inhibitory effects are 
poorly understood, they allow hormones to regulate genes 
without requiring the receptors to bind to DNA. 
DNA-Binding Motifs 
Nuclear receptors primarily act through direct association 
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with specific DNA sequences known as hormone re- 
sponse elements (HREs) (Evans, 1988; Beato, 1991). For 
the nonsteroid members of the receptor superfamily, the 
HREs consist of a minimal core hexad consensus se- 
quence, AGGTCA, that can be configured into a variety 
of structured motifs (see Figure 1 B) (Glass, 1994). These 
HREs directly reflect the mode of receptor binding, which 
can be as heterodimers, homodimers, or monomers. In 
contrast, the steroid hormone receptors bind exclusively 
as homodimers to palindromes separated by three nucleo- 
tides. 
The l-to-5 Rule 
Inherent in the property of each receptor is its ability to 
recognize HREs that are unique. A compilation of data 
from several laboratories has now shown that the most 
potent of these HREs are direct repeats (DRs) of the core 
AGGTCA half-site (reviewed by Mangelsdorf et al., 1994; 
Leid et al., 1992a). The idea of the DR response element 
was initially suggested by the studies on thyroid hormone 
(Koenig et al., 1987) and retinoic acid response elements 
(reviewed by Leid et al., 1992a). These observations were 
later developed into a model in which HREs for the vitamin 
D receptor (VDR), thyroid hormone receptor (TR), and reti- 
noic acid receptor (RAR) are composed of DRs spaced 
by 3, 4, or 5 nt (i.e., DR3, DR4, and DR5, respectively) 
(Umesono et al., 1991). The subsequent demonstration 
that a DRl serves as an RXR and peroxisome proliferator 
response element and a DR2 is a second retinoic acid 
response element has expanded the model to the so- 
called l-to-5 rule (reviewed by Mangelsdorf et al., 1994). 
In addition to spacing, subtle differences in the sequence 
of the hexad half-site and the 5’ extension of these re- 
sponse elements are also important and can have dra- 
matic effects on the activity of a receptor (Mader et al., 
1993; Vivanco Ruiz et al., 1991; Willy et al., 1995). As 
shown in Figure 2, several orphan receptors, including 
LXR (named for its liver-rich expression pattern), peroxi- 
some proliferator-activated receptor (PPAR), the nerve 
growth factor receptor-induced orphan receptor NGFI-B, 
and chicken ovalbumin upstream promoter transcription 
factor (COUP) (discussed below), mediate their responses 
through distinct DR sequences. 
In addition to the DR motifs, there are a variety of com- 
plex HREs. The TREpal (an inverted repeat [IR]) is acti- 
vated by the TR, RAR, and RXR (Umesono et al., 1988; 
Mangelsdorf et al., 1990); however, few target genes con- 
tain this motif. Rather, the physiologic HREs tend to be 
composed of DRs or everted repeats (ERs) or will include 
an IR as part of a complex element which may contain 
several core elements. By nature, all receptors that bind 
to either DRs or palindromic HREs do so as either hetero- 
dimers or homodimers (Figure 2). As discussed below, 
there are also a number of orphan receptors that can bind 
to only a single core element as a monomer. 
RXR, a Master Regulator 
In 1988 it was assumed that receptors such as the TR and 
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Figure 1. Nuclear Hormone Receptors Are Ligand-Dependent Tran- 
scription Factors 
(A) Schematic representation of a typical nuclear receptor. Receptors 
may be divided into five regions based on structure and function simi- 
larities (denoted A, 6, C, D, E, and F). Regions C and E contain the 
conserved DBDs and LBDs that are the signature of this superfamily 
(Evans, 1988; Green and Chambon, 1988). In addition, structurelfunc- 
tion studies have revealed the existence of a CTE to the DBD, a dimer- 
ization region within the LBD, and two transactivation domains (de- 
noted AF-1 and AF-2/r,). A second dimerization domain (not shown) 
exists in the DBD and is required for heterodimerization of receptors 
on DR response elements. 
(8) Nuclear receptor response elements are composed of DRs, IRS, 
and ERs of the hexad core sequence AGGTCA. Specificity for different 
hormone responses is given by the number of nucleotides (n) spaced 
between the two core elements. See text for details. 
(C) Mechanism of action of nuclear receptor heterodimers. In this 
scheme, the hormone activator (ligand) can be generated in at least 
three different ways: the ligand (e.g., thyroid hormone) may be synthe- 
sized at a source other than the target cell in classic endocrine fashion; 
the ligand (e.g., 9-cis retinoic acid) may be generated within the target 
cell from an apohormone (APO); or the ligand (e.g., prostaglandin) is 
synthesized intracellularly and is not secreted (Intra). 
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RAR, like the steroid receptors, functioned as homodi- 
mers. While the TR homodimer can be formed (Forman 
et al., 1989; Wahlstrdm et al., 1992) it soon became appar- 
ent that an accessory factor present in nuclear extracts 
was required for high affinity binding of VDR, TR, and RAR 
to their cognate HREs (reviewed by Glass, 1994). Shortly 
after the identification of RXR (Mangelsdorf et al., 1990), 
a series of experiments in several laboratories produced 
the consensual finding that RXR was the common missing 
factor (Vu et al., 1991; Kliewer et al., 1992a, 1992b; Leid 
et al., 1992b; Zhang et al., 1992; Marks et al., 1992; Bugge 
et al., 1992). There are now known to be three mammalian 
RXR isoforms, and, remarkably, these are the only pro- 
teins that can subserve this function (Mangelsdorf et al., 
1992; Leid et al., 199213). A list of RXR partners is shown 
in Figure 2. In Drosophila, the RXR homolog, Ultraspiracle, 
is a partner for the ecdysone receptor (reviewed by Thum- 
mel, 1995 [this issue of Cc//J), indicating that heterodimeri- 
zation evolved prior to the divergence of vertebrates and 
invertebrates. 
Because DRs are asymmetric, heterodimer complexes 
should bind these elements in an asymmetric fashion. In- 
deed, it has now been established that on DR3, DR4, and 
DR5, RXR occupies the 5’ half-site and the partner (e.g., 
VDR, TR, and RAR, respectively) occupies the 3’half-site 
(Perlmann et al., 1993; Kurokawa et al., 1993; Zechel et 
al., 1994). On DRl, RXR can bind as both a homodimer 
and as a heterodimer with RAR. Interestingly, the polarity 
of the RXRlRAR heterodimer on DRl is reversed (Kuro- 
kawa et al., 1994). In many cell types, the consequence 
of this reverse polarity binding is that the RARlRXR hetero- 
dimer is a potent repressor of the ligand-activated RXR 
homodimer (Mangelsdorf et al., 1991; Kurokawa et al., 
1995). 
Unexpectedly, the ligand-induced transcription activi- 
ties for RXR are suppressed when complexed with VDR, 
TR, and RAR. In RXR/TR and RXRIRAR, the formation 
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Figure 2. Nonsteroid Members of the Nuclear 
Receptor Superfamily Function as Heterodim- 
ers, Homodimers, and Monomers 
Listed in the columns next to the RXR hetero- 
dimer partner receptors are (left to right) known 
ligands (or activators); cognate response ele- 
ments of DR, IR, or ER motifs; and heterodim- 
ers that are also known to be responsive to the 
RXR ligand 9-cis retinoic acid (plus). (Asterisk) 
The RARlRXR heterodimer is a potent repres- 
sor on a DRl (Mangelsdorf et al., 1991) but 
has been shown to activate a DRI in some cells 
(Durand et al., 1992). (Dagger) These orphan 
receptors can bind as both homodimers and 
monomers. (Double dagger) COUPu, COUP& 
and COUPy are also known as COUP-TF-I 
(EARS), COUP-TF-II (ARPl), and EAR2; COUP 
has also been shown to heterodimerize with 
RXR. (Question mark) DAXl lacks a nuclear 
receptor DBD, and therefore its mode of DNA 
binding is not precisely known. Owing to space 
limitations, references for the various receptors 
are given in the overview by Mangelsdorf et al. 
(1995). 
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of the heterodimer actually prevents the RXR from binding 
its ligand (Kurokawa et al., 1994; Forman et al., 1995c). 
The restriction of RXR ligand binding within several of 
these heterodimers indicates that 9-cis retinoic acid re- 
sponsiveness is not an obligatory consequence of hetero- 
dimerization with RXR. Thus, in these instances, RXR is 
said to be a silent partner. Nonetheless, there are several 
examples in which RXR can be an active partner (see 
Figure 2) (reviewed by Leblanc and Stunnenberg, 1995). 
One example occurs in the PPARlRXR heterodimer, in 
which both receptors are independently responsive and 
are synergistically activated in the presence of both li- 
gands (Kliewer et al., 1992b). Similarly, heterodimeric 
complexes of RXR with the orphan receptor LXR or farne- 
soid X receptor (FXR) also retain 9-cis retinoic acid respon- 
siveness, further supporting the view that RXR can either 
be a silent partner or a hormone responsive partner (Willy 
et al., 1995; Forman et al., 1995a). The final and perhaps 
most unusual example of RXR responsiveness occurs in 
the complex formed with the orphan receptor NGFI-B 
(Perlmann and Jansson, 1995; Forman et al., 1995c). This 
receptor has been shown to contribute to T cell apoptosis 
and is capable of binding to target DNA as a monomer 
(see below). However, in the presence of RXR, it forms a 
stable heterodimer that is 9-cis retinoic acid responsive. 
Thus, RXR is a critical component of heterodimer forma- 
tion, which in turn is critical to generating diversity of hor- 
mone responses. 
Structure/Function Analysis of RXR Heterodimers 
As ligand-dependent transcription factors, the receptors 
must be understood in terms of the structural features that 
mediate heterodimerformation, ligand binding, sequence- 
specific DNA recognition, and the molecular events under- 
lying the switch from inactive to active receptors. In addi- 
tion to providing stereochemical understanding of the 
receptors themselves, such structural analyses provide 
a basis for understanding the topological details of the 
interaction of receptor complexes with coactivators, core- 
pressors, and other components of the transcriptional ma- 
chinery. 
The DNA-Binding Domain 
The size of intact receptors makes analysis of heterodim- 
eric complexes with ligand on target DNA a substantial 
structural problem. However, in the last year, the struc- 
tures of the DNA-binding domains (DBDs) of the RXR/TR 
heterodimer bound to a DR4 response element (Rasti- 
nejad et al., 1995), the ligand-binding domain (LBD) of 
human RXRa without hormone (Bourguet et al., 1995) 
and the LBD of human TRa with hormone (Wagner et al., 
1995) have been solved. Prior to 1995, nuclear magnetic 
resonance spectroscopy had been used to solve the solu- 
tion structure of both the RXR and RAR DBDs (Katahira 
et al., 1992; Lee et al., 1993) in the absence of DNA. These 
structures confirm many of the concfusions and predic- 
tions anticipated from previous biochemical studies as 
well as provide a wealth of stereochemical detail that could 
not be anticipated. 
The DBD of each of these receptors spans a “core” of 
Figure 3. X-Ray Crystal Structures 
(A) The structure of RXR (red) and TR (white) DBDs are shown bound 
to a DR4 sequence (taken from Rastinejad et al., 1995); zinc ions are 
shown in yellow. RXR resides in the 5’ position, and TR projects a 
carboxy-terminal helical tail across the minor groove. 
(B) The three-dimensional structure of an RXR LBD homodimer is 
shown (each monomer is in blue and green; anti-parallel 8 strands 
are red). The carboxy-terminal AF-2 domains project at a 4fP angle 
away from the structure. The two dimer structures have been con- 
nected by a white dot to provide a speculative model for an intact 
receptor complex on DNA. 
66 residues that forms a highly conserved domain encom- 
passing the two zinc finger modules followed by acarboxy- 
terminal extension (CTE). The core domain is conserved 
across all members of the receptor family and contains 
two a helices, one of which (the recognition helix) engages 
the major groove to make specific contacts with the bases 
of the half-site (Luisi et al., 1991; Schwabe et al., 1993). 
The X-ray structure of the RXR/TR reveals a polar head-to- 
tail assembly of the two proteins on DNA, with RXR occu- 
pying the upstream hexameric DNA repeat (Figure 3A; 
Rastinejad et al., 1995). The two monomers bind on one 
side of the DNA double helix, occupying adjacent major 
grooves. This arrangement is in contrast with that pre- 
viously seen for the steroid receptors, in which the palin- 
dromic DNA repeats impose a two-fold symmetry that re- 
sults in a head-to-head arrangement of the DBDs (Luisi 
et al., 1991; Schwabe et al., 1993). The head-to-tail ar- 
rangement brings distinct regions of each protein (the 
head and the tail) to their dimerization interface (see Figure 
3A). The nuclear magnetic resonance structure of the RXR 
DBD identified a third helix in the CTE that packed against 
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helix 1 (Lee et al., 1993) and that is required for cooperative 
homodimeric binding of RXR to DRl DNA. The recognition 
helices within each of the DBDs (Figure 3A) make base 
pair and backbone-phosphate contacts that are similar to 
those seen with the estrogen receptor DBD DNA structure 
(Schwabe et al., 1993). The CTE helix, with its extensive 
minor groove contacts, effectively extends the contact sur- 
face of the TR DBD to beyond the consensus 6 bp half-site. 
This is analogous to certain receptors, like NGFI-B and 
the retinoid-related orphan receptor (ROR), that also bind 
stably as monomers by using the CTE to extend the DNA- 
binding surface (Wilson et al., 1993; McBroom et al., 
1995). 
The RXR/TR DBD structure sheds light on a very im- 
portant issue in receptor biology. How can a large family 
of related proteins be engineered to recognize a wide rep- 
ertoire of DNA-binding motifs and yet employ RXR as a 
common partner? With regard to DR DNA targets, a 
change of one nucleotide in the spacer requires the RXR 
partner to rotate approximately 36O around the double he- 
lix and be translated 3.4 A. The consequence of such 
movement is that RXR cannot interact with a common 
interface in each of its partners. Rather, it must possess 
a series of nested surfaces that correspond to the rota- 
tional and distance changes of its partners. The RXR DBD 
acts as a type of gear allowing sprockets (amino acids) 
from the downstream subunit to be engaged only in the 
appropriate stereochemical alignment. The downstream 
partner (e.g., TR) need only have a single dimerization 
interface that projects toward the upstream partner (e.g., 
RXR). One characteristic of such an arrangement is that 
it would be impossible for multimeric complexes to form, 
since the downstream subunit contains only a single inter- 
face that projects toward the spacer. 
These structural studies indicate the DNA spacer to be 
a critical determinant of heterodimer DBD complex forma- 
tion. The receptors can bind to alternative response ele- 
ments, including IRS and ERs, but in contrast with DRs, 
on symmetrical DNA targets, the DBDs fail to form a coop- 
erative dimerization interface, and, thus, cooperativity is 
entirely dependent on the dimerization interface in the 
LBDs (see below). 
The Ligand-Binding Domain 
Previous studies have revealed the LBD to comprise a 
carboxy-terminal region of approximately 225 amino acids 
that is capable of autonomous ligand binding (Evans, 
1988; Green and Chambon, 1988). In addition to function- 
ing as a LBD, this region also includes homo- and hetero- 
dimerization interfaces, hormone-dependent transcrip- 
tional activation functions, and (in some cases) hormone 
reversible transcriptional repression. Currently, structures 
of the unliganded human RXRa LBD and liganded TRa 
LBD have been determined using X-ray crystallography 
to resolutions of 2.7 and 2.2 A, respectively (Bourguet et 
al., 1995; Wagner et al., 1995). While the structures are 
broadly similar, they have marked differences that may 
have important functional consequences. Approximately 
65% of their entire domains are a-helical, crystallizing as 
a homodimer in the case of RXR and as a monomer in the 
case of TR. This structure has been termed an antiparallel 
a-helical sandwich because the helices are grouped into 
three layers harboring an internal ligand-binding core (see 
Figure 38). In RXR, a symmetrical structure is observed 
whose interface helps to identify the putative dimerization 
surface. 
As described above, all ligand-activated receptors ap- 
pearto possess acarboxy-terminal activation function var- 
iously termed AF-2 or ~~ (also termed Tau-4). In the nonli- 
ganded RXR, the activation domain forms an amphipathic 
a helix that extends into the solvent at an approximately 
45’ angle from the body of the core structure (Bourguet 
et al., 1995) (Figure 3B). In contrast, in the liganded TR, 
the AF-2/r, domain is packed onto the body of the receptor 
with a portion of it forming part of the ligand-binding 
pocket. These results raise several questions about the 
nature of the activation process itself. Prior to considering 
models of activation, it is worthwhile to consider the basis 
of ligand binding. Remarkably, in TR, the ligand is com- 
pletely buried within the interior of the structure and contri- 
butes to the hydrophobic core of the protein. Contacts with 
the ligand are extensive and include at least eight different 
structural elements throughout the length of the LBD. 
Comparisons of the RXR and TR structures suggest sub- 
stantial allosteric changes occur upon ligand binding. In- 
deed, the buried nature of the ligand may relate to the 
low dissociation constants of receptors for their cognate 
hormone. In contrast, in RXR, this region is relatively ex- 
posed, suggesting adramatic change upon ligand binding. 
Heterodimeric Complexes 
Future studies will require crystal structure of intact (full- 
length) receptor heterodimers on target DNA in both the 
presence and absence of ligand. This will provide informa- 
tion on the properties of heterodimers and the conse- 
quences of ligand binding on the RXR AF-2/r, domain. 
Nonetheless, the structures for the RXRlTR DBDs on 
DNA, along with the structures for the RXR LBD, allow us 
to model how these units might come together to form an 
intact hormone-dependent transcription factor (Figures 3A 
and 38). The first step of this model building requires artifi- 
cially linking the DBD structure to the LBD complex. The 
imaginary connection is shown in Figure 3 by a white dot 
between the TR DBD and the RXR LBD, since the gap 
between the DBD and LBD has yet to be seen in the crystal 
structures. In this model, it should be apparent that the 
LBD heterodimer structure is symmetrical, whereas the 
DBD heterodimer structure is an asymmetrical head-to-tail 
assembly. Thus, the TR DBD is rotated 180“ relative to its 
LBD. The carboxyl termini of both DBDs appear to traverse 
the minor groove, projecting orthogonally across the axis 
of the double helix toward the LBDs. The region between 
the DBDs and LBDs would constitute a short hinge that 
might be required to accommodate rotational differences 
associated with receptor binding to DRs, IRS, or ERs. 
The Two-Step Dimerization Pathway 
The above studies indicate that the receptors contain two 
independent dimerization motifs, one within the carboxy- 
terminal LBD and a second within the conserved DNA- 
binding core. The two dimerization domains appear to 
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work in sequence and lead to a two-step hypothesis for 
binding of heterodimers to DNA. In the first step, RXR 
would form solution heterodimers with its partners through 
their LBDs. In the second step, the DBDs, by virtue of their 
proximity, would be able to bind high affinity sites in DNA. 
Because the target DNAs can be composed of IR and ER 
DNA as well as DR DNA, the DBDs must retain spatial 
flexibility. This flexibility may be viewed as a rotational 
capability that allows the DBDs to “swivel” according to 
the orientations of the various half-sites such that each 
DNA-binding head must be able to rotate at least 180’ 
relative to the LBD. The second dimerization interface can 
be formed only on DR DNA. Once bound to DNA, the 
receptors are capable of modulating transcription. To un- 
derstand the mechanisms underlying hormonal activation, 
researchers have focused recently on the interaction of 
the receptors and the transcriptional machinery. 
Cofactors 
A yeast two-hybrid based screen has identified two related 
proteins that interact with both the TR and RARs, termed 
SMRT (for silencing mediator for RARs and TRs) and 
N-CoR (for nuclear receptor corepressor) (Chen and Ev- 
ans, 1995; Horlein et al., 1995). These proteins interact 
with unliganded receptors and are released upon ligand 
binding. The carboxyl termini of both proteins contain a 
receptor interaction domain while the amino-terminal por- 
tion contains two novel repressor motifs. In the absence 
of ligand, the hormone repressor remains associated with 
the receptor, resulting in a strong inhibition of basal tran- 
scription activity of the associated promoter (Figure 4). 
Following hormone treatment, the repressor dissociates, 
relieving suppression and allowing net activation. The car- 
boxy-terminal transactivation (AF-2) domain is required for 
the dissociation of the cofactor, suggesting a mechanistic 
link between transcriptional suppression and activation 
(Chen and Evans, 1995). Several potential positive cofac- 
tors have also been identified, including Trip1 (Lee et al., 
1995; vom Bauret al., 1995), TlFl (Le Douarinetal., 1995), 
RIP140 and RIP160 (also known as ERAP160) (Cavailles 
et al., 1995; Halachmi et al., 1994). Trip1 is homologous 
to the yeast SUGl protein and interacts with the AF-2/~, 
domain of TR, RAR, VDR, and estrogen receptor and 
weakly with RXR (Lee et al., 1995; vom Baur et al., 1995) 
in a hormone-dependent fashion. TlFl contains a RING 
finger motif and also interacts with the AF-2/?, domains 
of RAR, RXR, and estrogen receptor (Le Douarin et al., 
1995). Finally, ERAP160 and RIP140 are novel proteins 
that bind the estrogen receptor, RAR, and TR AF-2/z, re- 
gion in a hormone-dependent fashion. How and why so 
many distinct classes of proteins interact with the AF-2/7, 
domain is unclear. Perhaps the presence of two AF-2/~, 
domains in a heterodimer allows for multiple distinct inter- 
actions. Further complicating these observations are the 
reports that the amino terminus of TR interacts specifically 
with TFIIB (Baniahmad et al., 1993) and that AF-2/z, of 
RXR directly interacts with TATA-binding protein both in 
vivo and in vitro (Schulman et al., 1995), suggesting that 
an individual receptor may possess multiple pathways for 
activation. 
An ultimate means of dissecting the mechanism of li- 
gand-dependent transactivation may come from in vitro 
transcription studies. The recent studies of Fondell et al. 
(1993) Valcarcel et al. (1994) and Lee et al. (1994) are 
promising and confirm the findings that RXR is an integral 
auxiliary factor and that the ligand-activated complex di- 
rectly interacts with the transcriptional machinery. 
The Orphan Receptors 
The term orphan receptor was coined in the late 1980s 
to describe the first of what has become a large number 
of novel gene products that by homology belong to the 
nuclear receptor superfamily, but for which ligands are 
initially unknown. It is now recognized that the term orphan 
receptor may in some cases be a misnomer, since not all 
of these proteins are likely to be ligand dependent. To 
date, over 30 different subfamilies of orphan receptors, 
each having multiple members, have been characterized 
in virtually every class of multicellular organism (see 
Mangelsdorf et al., 1995 [this issue of Ce/fj). A major chal- 
lenge is to decipher the function of these proteins, to deter- 
mine whether they are hormone responsive, and, if so, to 
identify their cognate ligands. An initial understanding of 
orphan receptor function is established through compara- 
tive studies of sequence identity, DNA-binding, dimeriza- 
tion, and ligand-independent activities. This approach 
allows the orphans to be classified into four categories. 
Within each category, several representative examples 
are discussed (see Figure 2). As described below, these 
Figure 4. A Two-Step Model for RXR Hetero- 
dimer Receptor Activation 
In this model, the heterodimer receptor com- 
plex (in this case, RXR-TR) is bound to its DR 
response element in the promoter of the target 
gene. In step one, ligand (T3) binding induces 
a conformation change in the TR that relieves 
basal repression by displacing the corepressor 
REPRESSED BASAL ACTIVATED 
(e.g., SMRT or N-CoR) and exposing the activa- 
tion domain. In step two, the complex tiinds 
a coactivator, which results in the observed 
ligand-dependent induction of transcription 
above the basal level. 
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categories are not mutually exclusive, giving many orphan 
receptors the potential to participate in several signaling 
pathways. 
The first category of orphan receptors is of those that 
heterodimerize with RXR. Like other RXR partners, these 
receptors require RXR for high affinity binding to their cog- 
nate response elements, which, as discussed above, are 
composed of at least two hexad half-sites arranged as 
either DRs or symmetric repeats. These heterodimers 
have the potential to respond to 9-cis retinoic acid, a novel 
ligand, or both. For example, RXR heterodimers with LXR, 
NGFI-6, and FXR all respond to 9&s retinoic acid, as 
shown in Figure 2(reviewed by Leblancand Stunnenberg, 
1995). Thus, these heterodimeric receptors constitute 
novel retinoid signaling pathways and are potential targets 
of orphan ligands (see below). 
The second category of orphan receptors is of those 
that bind DNA as homodimers. In contrast with the steroid 
receptor homodimers, orphan receptor homodimers can 
bind to both palindromic and DR response elements. Many 
of these binding sequences overlap with response ele- 
ments for other hormone receptors, suggesting they may 
modulate known hormone signaling pathways. The di- 
merit orphan receptors are typically strong constitutive 
transactivators or transrepressors, suggesting that they 
may be ligand independent (reviewed by Conneely and 
O’Malley, 1994). The two examples described below typify 
this class. The first is the orphan receptor hepatocyte nu- 
clear factor 4 (HNF4), which binds as a homodimer to a 
DRl element and is a strong constitutive transcriptional 
activator (Jiang et al., 1995). Although this result suggests 
that HNM is not ligand-dependent, the presence of an 
endogenous ligand can not be excluded. In contrast with 
HNF4, the COUPs (which include EAR2, EAR3, and ARPl) 
are potent dominant repressors of both basal transcription 
and transactivation by several receptors, including RXR, 
RAR, VDR, and TR (Conneely and O’Malley, 1994). Re- 
pression of these pathways by COUP is believed to be 
accomplished in part by direct competitive binding and 
by the presence of a strong carboxy-terminal repressor 
domain. COUP can also heterodimerize with RXR, thereby 
titrating RXR into a transcriptionally inactive complex. 
Taken together with the ability of COUP to bind to DRl 
to DR5 response elements, these studies (see Conneely 
and O’Malley, 1994, and references therein) suggest 
COUP may play a general role as a negative regulator to 
keep target genes off in the absence of hormone, thus 
enhancing the dynamic effect of ligand. Thus, even though 
members of this group may not have ligands, they could 
function to establish a dynamic equilibrium with other re- 
ceptors to modulate the hormonal response. 
In the third category, orphan receptors that bind to DNA 
as monomers appear to be positive regulators of transcrip- 
tion, and, like the homodimeric orphans, many display 
constitutive activity. The monomeric orphan receptors 
bind to an extended half-site of AGGTCA in which the 5’ 
flanking nucleotides participate in determining the speci- 
ficity that is unique to each of these receptors (McBroom 
et al., 1995; Wilson et al., 1993; Harding and Lazar, 1993). 
In addition to the protein-DNA contacts that are made 
between the conserved DBD of the receptor and the 
AGGTCA half-site, a CTE of the DBD contacts the first l- 
3 nt immediately 5’of the core site (McBroom et al., 1995; 
Wilson et al., 1993). Differences in the CTE of individual 
receptors determine the different monomer-binding sites. 
This DNA binding specificity can be further modified by 
the amino terminus of the receptor, which, in the case of 
the two isoforms of the orphan RORa, forces the CTE 
of each isoform to recognize different sets of base pair 
contacts in the 5’ flanking nucleotides of the core site 
(McBroom et al., 1995). Steroidogenic factor (SF-l) is a 
homolog of the Drosophila Fushi tarazu factor 1 (FTZ-Fl) 
protein that illustrates the physiologic importance of mono- 
meric orphan receptors (Lala et al., 1992). SF-1 is constitu- 
tively active and expressed in all steroidogenic tissues 
(especially adrenals, gonads, and placenta) as well as in 
tissues involved in steroid regulation, such as pituitary and 
hypothalamus. It binds to enhancers for most steroido- 
genie enzymes, and its loss by gene knockout leads to 
complete agenesis of the adrenal/gonadal axis and conse- 
quently to a total absence of steroid synthesis (reviewed 
by Kastner et al., 1995 [this issue of Cc//J). Thus, it serves 
as an example of a nuclear receptor that controls produc- 
tion of hormones for other nuclear receptors. 
The fourth category of orphan receptors includes sev- 
eral unique members of the family that do not contain both 
a DBD and LBD. For example, the DAXl protein contains 
only an LBD (Zanaria et al., 1994); it was identified by 
positional cloning of the locus for X-linked adrenal hypo- 
plasia congenita in humans (Kastner et al., 1995). In con- 
trast with DAXl, the Drosophila Knirps and related genes 
have only a DBD (reviewed by Thummel, 1995). The dis- 
covery of these proteins gives credence to the hypothesis 
that the LBD and DBD, which are the very signature of a 
nuclear receptor, evolved independently and are function- 
ally modular. 
What’s My Ligand? 
When the first orphan receptors were cloned, it was axio- 
matic that they would be bona fide receptors and that 
searching for their cognate ligands would establish the 
foundation for a whole new direction in nuclear receptor 
research. However, the subsequent cloning of orphan re- 
ceptors in numbers that well exceed the lists of even the 
most optimistic estimates of candidate activators eventu- 
ally has led to the belief that not all of these proteins may 
have ligands. Nonetheless, some of these orphans are 
undoubtedly ligand responsive. Although it is not yet possi- 
ble to predict which these might be, there are two features 
common to all nonsteroid receptors that have known Ii- 
gands: all of the known ligands are small lipophilic com- 
pounds, and RXR is a common component of the receptor 
complexes. These results suggest that orphan receptors 
that utilize RXR as a dimerization partner are favorable 
candidates for activation by orphan ligands. 
The major strategy for identifying orphan receptor li- 
gands has been the use of the cotransfection screening 
assay in which the orphan receptor activates a reporter 
plasmid in the presence of a cognate ligand. Using this 
strategy, at least six lipophilic hormone-like activators 
have been discovered for orphan receptors. The earliest 
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class of compounds to be identified as ligands for orphan 
receptors were the retinoids. Thus, the RAR was the first 
known orphan receptor for which a ligand (all-frans retinoic 
acid) was identified (Giguere et al., 1987; Petkovich et al., 
1987). This was soon followed by the observation that the 
RXR could be activated by, but not bind to, all-frans retinoic 
acid (Mangelsdorf et al., 1990). The hunt for its true ligand 
(retinoid X) led two groups working independently and us- 
ing different techniques to the discovery that a stereoiso- 
mer of retinoic acid, 9-cis retinoic acid, is a high affinity 
RXR ligand (Heyman et al., 1992; Levin et al., 1992). 9-cis 
retinoic acid was the first natural ligand to be discovered 
for the nuclear receptor superfamily since the character- 
ization of the active form of vitamin D. The discovery of 
RAR and RXR as two retinoid signaling pathways has 
greatly contributed to our understanding of the develop- 
mental and physiologic networks governed by vitamin A 
(reviewed by Mangelsdorf et al., 1994; Leid et al., 1992a). 
Recently, several noncyclic terpenoids have been 
shown to bind and activate RXR (Harmon et al., 1995). 
Unlike 9-cis retinoic acid, these compounds are highly se- 
lective for RXR and do not activate RAR. One of these 
compounds in particular, methoprene acid, is a metabolite 
of the widely used pesticide methoprene. Methoprene is 
a juvenile hormone analog that acts to retain juvenile char- 
acteristics during insect growth, thereby preventing matu- 
ration into an adult. One recent study has also identified 
juvenile hormone and farnesol as activators of a hetero- 
dimeric complex between RXR and the FXR (Forman et 
al., 1995a). Since neither juvenile hormone nor farnesol 
has been demonstrated to bind to the FXRlRXR hetero- 
dimer, it is likely that a closely related metabolite may be 
a high affinity ligand. 
lssemann and Green (1990) identified PPARa as an 
orphan receptor that was activated by compounds that 
induce peroxisomal proliferation. Subsequently, it was 
shown that PPARa is activated by long-chain fatty acids 
and by compounds that inhibit their catabolism (Gdttlicher 
et al., 1992; Keller et al., 1993). These results suggest 
that a natural ligand for PPARa may be a long-chain fatty 
acid that accumulates upon inhibition of b-oxidation. Al- 
though the actual PPARa ligand remains elusive, it ap- 
pears that PPARa plays a central role in a feedback loop 
that regulates and responds to changing levels of fatty 
acid derivatives. In addition to PPARa, two closely related 
receptors have been identified termed, PPARy and 
PPARS (also termed Nut-1), which appear to respond to 
a different profile of activators (Schmidt et al., 1992; 
Kliewer et al., 1994). Important insights into the physiologi- 
cal function of PPARy have come from recent experiments 
demonstrating that this receptor plays a central role in 
adipogenesis (Tontonoz et al., 1994). This finding prompted 
an intense search for PPARy ligands, which led to the 
recent discovery that a class of synthetic antidiabetic 
agents (thiazolidinediones) are high affinity ligands (Leh- 
mann et al., 1995). Thiazolidinediones are analogs of 
prostanoids, and this observation led two groups indepen- 
dently to identify 15deoxy-A 12.14-prostaglandin Jp as a nat- 
ural PPARy ligand (Forman et al., 1995b; Kliewer et al., 
1995). Taken together, these results suggest an unex- 
petted molecular linkage among prostanoids, adipogen- 
esis, and glucose homeostasis. 
Summary and Perspectives 
The last 10 years have witnessed an explosion in the clon- 
ing of the nuclear receptors and, consequently, our under- 
standing of hormone action. Analysis of these proteins 
has also provided important insight as to how individual 
transcription factors can affect cell fate and function. 
Through their cloning, we have learned that receptors for 
steroids, retinoids, thyroid hormones, and vitamin D share 
a common structure and, thus, that these hormones have 
a common underlying mechanism of action. While appar- 
ently all receptors for steroid hormones have been cloned, 
the RXR heterodimers and orphan receptors are continu- 
ing to be identified and represent the largest numerical 
portion of this family. From this evolving family, we have 
learned that receptor heterodimerization has been a criti- 
cal component of the evolution of endocrine signaling 
pathways, spanning both invertebrates and vertebrate 
systems. At its center is the common heterodimerization 
partner RXR, which has also evolved an overlapping role 
in retinoid signaling. The reason a retinoic acid receptor 
should have such a role is not clear, but it suggests that 
vitamin A signaling may be inextricably linked to many 
endocrine pathways. The further discovery of orphan re- 
ceptors leads to the implied existence of new classes of 
physiologic regulators that can be anticipated to have a 
widespread impact on embryology as well as classic 
branches of physiology. This field has also moved at a 
breathtaking pace. The discovery of receptors has ulti- 
mately yielded structure/function studies of the encoded 
proteins and a mechanistic basis for hormonal signaling. 
X-ray crystallography has provided our first views on the 
mechanisms by which receptor’heterodimers form and 
recognize specific target DNA, as well as provided the 
chemical insights into the role of hormone in receptor acti- 
vation. With the advent of structural studies, it seems ap- 
parent that in a relatively short time, we have traversed 
the distance from general models to a specific chemical 
basis of hormone action. 
This review has stressed the commonalities among the 
various signaling pathways that lead to an overall unifying 
view of hormonal signaling. While it is possible to consider 
each receptor or each hormone in isolation and to extract 
common themes, body physiology is rarely so simple. For 
example, intermediary metabolism may be considered the 
sum of all the chemical reactions that occur within an or- 
ganism between the intake of chemical nutrients and oxy- 
gen and the elimination of chemical byproducts, water, 
and carbon dioxide. Hormones are effective regulators 
of intermediary metabolism by controlling the intensity, 
timing, or direction of metabolic steps, most often by af- 
fecting the synthesisof appropriateenzymes. While recep- 
tors or hormones can be viewed in isolation, a future chal- 
lenge is to elucidate the contributions of these individual 
systems to the integrated and complex processes associ- 
ated with the multihormonal nature of metabolic regula- 
tion, embryonic development, and the cascade of prob- 
lems that impact many systems when a single hormonal 
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imbalance occurs. Thus, while the advances of the last 
10 years can be viewed with satisfaction, there is still a 
long and challenging journey ahead. 
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